Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Current Liabilities

$8.02M

Quarterly · Period ending: · USD

LCTX logo

LCTX Total Current Liabilities

Latest reported$8.02M
LCTX Quarterly Current Liabilities ($200.00K → $8.02M)
High-resolution chart · PNG

LCTX total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
8,016,000
8,148,000
11,367,000
9,382,000
10,756,000
13,089,000
13,977,000
13,864,000
15,275,000
16,890,000
17,960,000
15,881,000
16,052,000
17,225,000
18,981,000
22,739,000
25,091,000
24,593,000
47,116,000
8,791,000
6,768,000
6,621,000
7,769,000
7,751,000
7,519,000
6,969,000
6,494,000
6,162,000
7,859,000
8,723,000
6,812,000
4,503,000
5,843,000
5,810,000
6,879,000
6,012,000
13,530,000
8,820,000
8,850,000
8,338,000
7,403,000
13,669,000
12,462,000
10,336,000
9,192,000
8,202,661
7,129,267
5,788,860
5,069,465
5,620,657
6,957,900
4,598,296
4,434,997
4,295,370
4,390,832
2,572,803
2,962,209
1,965,529
3,146,655
2,722,286
3,286,882
2,726,970
2,479,957
1,299,404
1,382,483
1,126,796
1,162,259
1,137,429
4,249,609
4,483,748
3,378,517
3,964,526
2,840,291
2,183,884
1,458,002
991,022
929,488
839,096
615,648
497,682
461,007
437,989
706,597
235,210
266,578
267,893
275,256
131,093
147,811
185,190
3,094,283
2,703,855
317,479
428,753
498,423
278,037
355,641
189,643
309,347
3,452,232
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.